, BPC 157 reversed NO-system blockade-complete failure of fistulas healing (35), and the same BPC 157-NO-system interaction was also seen in other models and in various species (4, 8, 25-27))
Once prescribed, peptide therapy is most often administered through injections (subcutaneously, intramuscularly, or intravenously), but some peptides can be administered orally, too
BPC-157 Peptide, also known as Pentadecapeptide BPC-157, or Body Protection Compound 157, is a wholly synthetic peptide that is potentially linked to multiple cellular functions and is perceived to have significance in healing of experimental models of injury
FDA also identified potential immunogenicity concerns associated with peptide aggregation and related impurities
All these together help to perform better overall